Skip to main content
. 2020 Nov 4;137(6):733–742. doi: 10.1182/blood.2020008021

Figure 4.

Figure 4.

Cumulative percentage of patients who achieved ADAMTS13 activity ≥ 20% after the last therapeutic plasma exchange in the triplet regimen (red columns) and the historical cohort (blue columns). ADAMTS13 activity was assessed weekly until normalization or day 56.